Continuous intravenous infusion of sodium thiopental for managing drug withdrawal syndromes.
This report describes the successful use of sodium thiopental by continuous infusion in three patients with drug withdrawal syndromes and the concomitant need for mechanical support of ventilation. This approach provided the sedation necessary so the patients could be effectively ventilated while simultaneously controlling the manifestations of drug withdrawal.
D000328:Adult; D000431:Ethanol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008614:Meperidine / Q000009:adverse effects*; D008875:Middle Aged; D012121:Respiration, Artificial; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D013874:Thiopental / Q000008:administration & dosage / Q000627:therapeutic use*
D000431:Ethanol; D008614:Meperidine; D013874:Thiopental